Home / Companies / Quest Intl., Inc.

Quest Intl., Inc.

FDA Regulatory Profile

Summary

Total Recalls
0
510(k) Clearances
25
Inspections
0
Compliance Actions
0

Recent 510(k) Clearances

K-NumberDeviceDate
K091260SERAQUEST EBV EA-D IGG TESTJune 8, 2009
K033915MODIFICATION TO SERAQUEST EB VCA IGGJanuary 16, 2004
K033780MODIFICATION TO SERAQUEST VCA IGMJanuary 15, 2004
K023593SERAQUEST ANTI-THYROID PEROXIDASE (TPO)February 6, 2003
K023592SERAQUEST ANTI-THYROGLOBULINJanuary 6, 2003
K003069ANTI-CARDIOLIPIN, MULTIPLE AUTOANTIBODIES IMMUNOLOGICAL TEST SYSTEMNovember 27, 2000
K991975SERAQUEST EB NA IGGNovember 2, 1999
K990410SERAQUEST EB VCA IGGOctober 28, 1999
K990977SERAQUEST EB VAC IGMOctober 6, 1999
K982485SERAQUEST CMV IGMJanuary 13, 1999
K982281SERAQUEST RUBELLA IGMOctober 16, 1998
K980540SERAQUEST ANTI-SMJune 15, 1998
K980639SERAQUEST ANTI-SSBJune 15, 1998
K980810SERAQUEST ANTI-SSAMay 12, 1998
K980811SERAQUEST ANTI-SM/RNPMay 12, 1998
K980391SERAQUEST ANTI-DSDNAApril 24, 1998
K980059SERAQUEST MUMPS IGGApril 23, 1998
K972295SERAQUEST VZV IGGNovember 5, 1997
K971672SERAQUEST TOXOPLASMA IGMOctober 21, 1997
K963282SERAQUEST HSV IGGJanuary 22, 1997